跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
助因止 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Susoctocog Alfa for Injection
Approved
生物制品
Susoctocog Alfa for Injection
Takeda Pharmaceuticals U.S.A., Inc.
🇨🇳 National Medical Products Administration
Approval Date
Feb 20, 2024
Approval ID
8Xx2hDvTRIY
Company
Takeda Pharmaceuticals U.S.A., Inc.
Type
生物制品
Approval Details
Approval Id
8Xx2hDvTRIY
Approval Number
国药准字SJ20240009
Generic Name
注射用舒索凝血素α
Generic Name En
Susoctocog Alfa for Injection
Trade Name
助因止
Drug Type
生物制品
Dosage Form
注射剂
Strength
500 U/瓶
Reg Date
2024-02-20
Expired Date
2029-02-19
Company Name
Takeda Pharmaceuticals U.S.A., Inc.
Production Company Name
Vetter Pharma-Fertigung GmbH & Co. KG
Company Detail Path
/organization/takeda-pharmaceuticals-u-s-a-inc
Production Company Detail Path
/organization/vetter-pharma-fertigung-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 20, 2024
Approval ID
8Xx2hDvTRIY
Type
生物制品
Back to NMPA Approvals